# AbbVie Inc.: Form 8-K, filed Sep 10, 2024

- Company: [AbbVie Inc.](/companies/abbv.md) (CIK 1551152)
- Form: 8-K
- Filed: 2024-09-10
- Accepted by EDGAR: Sep 10, 2024, 15:30 ET
- Period: 2024-09-06
- Accession: 0001104659-24-098564
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/tm2423380d1_8k.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/

## Items reported

- Item 5.03: Amendment to articles or bylaws
- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1551152/000110465924098564/tm2423380d1_8k.htm

Filed Sep 10, 2024.
Source: SEC EDGAR, the filing index for accession 0001104659-24-098564. Last ingested by Listed: Oct 30, 2026, 07:53 ET. No prices; not investment advice.